HWM
ALT icon

Horizon Wealth Management’s Altimmune ALT Stock Holding History

Horizon Wealth Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,000
Closed -$58K – 127
2025
Q2 		$58K Sell
15,000
-10,000
-40% -$54.1K 0.01% 107
2025
Q1 		$125K Buy
+25,000
New +$158K 0.02% 102
2024
Q3 		– Sell
-10,000
Closed -$66.5K – 87
2024
Q2 		$66.5K Buy
+10,000
New +$73.8K 0.02% 78
2024
Q1 		– Sell
-10,000
Closed -$113K – 89
2023
Q4 		$113K Buy
+10,000
New +$41.8K 0.03% 79

Other funds holding ALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Horizon Wealth Management's ALT Position: Q3 2025 in Review

Horizon Wealth Management sold out of Altimmune (ALT) in Q3 2025, closing a stake of 15,000 shares — an estimated $58K sold.

Horizon Wealth Management first reported a position in ALT in Q4 2023 and held it in 4 quarters. The position peaked at $125K in Q1 2025. 158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

  • Horizon Wealth Management reported no remaining Altimmune position as of Q3 2025 after selling out during the quarter.
  • Horizon Wealth Management sold 15,000 Altimmune shares in Q3 2025, an estimated $58K.
  • Horizon Wealth Management first reported a position in Altimmune in Q4 2023 and held it in 4 quarters.
  • Horizon Wealth Management's Altimmune position peaked at $125K in Q1 2025.
  • 158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on Horizon Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.